MACOA Health

What MACOA Health does

MACOA Health (legal name: Medical Advancement Centers of Arizona) is a privately held, single-site clinical research organization founded in 2020 in Phoenix, Arizona. The company operates a clinical trial site that recruits and conducts studies on behalf of pharmaceutical sponsors and CROs, with a stated focus on enrolling patients from underserved communities. Its therapeutic portfolio spans respiratory disease (COPD, moderate-to-severe asthma), infectious disease (COVID-19, meningococcal B vaccine, RSV), dermatology (eczema in adults and adolescents), hepatology (liver cirrhosis), and neurology (dementia). The site serves two principal customers: pharmaceutical sponsors and CROs on the study-supply side, and patients who participate in trials on the demand side.

The company's infrastructure is built around a 17-bed Phase I and pharmacokinetic capacity, on-site pulmonary function testing (PFTs) with DLCO, EKG capability, a CLIA-waived diagnostic lab, dedicated pharmacists, and temperature-controlled storage at -20°C and -70°C with continuous monitoring and backup power. Operations are run on a full electronic Clinical Trial Management System covering eSource, eReg, eConsent, and eISF with remote CRA access for monitors, and the company cites a 72-hour regulatory document turnaround and 7-day clinical trial agreement turnaround. Compliance footprint includes CLIA-waived status, IBC approval, and HIPAA compliance. Clinical depth is anchored by Primary Investigator Jeffrey Hoodin, M.D. (40+ years as an internist, 100+ studies across 10 therapeutic areas) and additional staff including a biomedical-trained clinical research coordinator.

Revenue is generated through contract research agreements with pharmaceutical sponsors and CROs (Amgen, AstraZeneca, Pfizer, Janssen, GSK are named), structured as professional-services contracts under which MACOA executes enrollment, study procedures, data capture, and regulatory compliance, with participant stipends (e.g., up to $1,200 for a 15-visit COPD/asthma study) administered as pass-throughs. Revenue is not publicly disclosed; the firm operates from a single Phoenix facility with a reported headcount of seven employees, indicating a small-scale operator whose growth depends on expanding sponsor relationships, therapeutic diversity, and PI bench capacity rather than geographic or channel breadth at present.

Name

MACOA Health

Legal name

Medical Advancement Centers of Arizona

Website

https://macoa-health.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

MACOA Health is a Phoenix-based clinical research site founded in 2020 that runs Phase I-IV trials for pharmaceutical sponsors (Amgen, AstraZeneca, Pfizer, Janssen, GSK) across respiratory, infectious disease, dermatology, hepatology, and neurology, focusing on recruiting underserved patient populations in the Phoenix metro area.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAC

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAG

Clinical Trial Monitoring Support (On-site/Remote)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAL

Site Data Management Support (EDC/Source/SDV Readiness)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLACAOAJ

Site & Investigator Platforms (Site Payments, Feasibility, Activation)

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

• Clinical research services
• Clinical trial site
• Patient recruitment
• Phase I trials
• Respiratory clinical trials

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Contracts: MACOA Health conducts clinical trials on behalf of pharmaceutical sponsors and CROs. Revenue is generated through contract research agreements where sponsors pay for clinical trial services including patient recruitment, study execution, data collection, and regulatory compliance.
2. Participant Compensation Administration: Study participants receive compensation for time and travel, which is administered through the organization. This represents a pass-through cost reimbursed by sponsors.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

MACOA Health operates as a clinical research site that recruits and enrolls patients into pharmaceutical-sponsored clinical trials across respiratory (COPD, asthma, RSV), infectious disease (COVID-19, meningitis), dermatology (eczema), hepatic, and dementia indications. The site delivers protocol execution, data collection, and regulatory compliance services on a contract basis to sponsors and CROs, while participants receive study-related care and investigational medications at no cost. Operations are supported by on-site PFTs, a 17-bed Phase I unit, CLIA-waived diagnostics, and a full CTMS platform.

Product overview

MACOA Health operates as a clinical research organization offering a portfolio of clinical trials across multiple therapeutic areas. The core offering consists of clinical trial participation services for conditions including respiratory diseases (COPD, Asthma), meningitis vaccines, COVID-19, eczema (adults and pediatrics), RSV, liver cirrhosis, and dementia. The company provides facilities and infrastructure for conducting clinical research, including on-site pulmonary function testing, EKG capability, a CLIA-waived diagnostic laboratory, dedicated pharmacists, and a 17-bed capacity for pharmacokinetic and Phase I studies. The company also maintains an investigator network connecting clinical trial investigators with their research operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Site Services Comprehensive clinical trial site services for pharmaceutical sponsors and CROs, including patient recruitment, study execution, on-site Pulmonary Function Testing (PFTs) and DLCO, EKG, CLIA-waived diagnostics, on-site pharmacy, temperature-controlled investigational product storage (-20°C and -70°C), and a 17-bed Phase I unit for pharmacokinetic and extended-stay studies. The site conducts trials across respiratory (COPD, asthma, RSV), infectious disease (COVID-19, meningitis/MenB vaccine), dermatology (eczema in adults and pediatric 12-17), liver cirrhosis, and dementia indications with a full CTMS (eSource, eReg, eConsent, eISF) including remote CRA monitoring access.
• Investigator Network Network enabling licensed physicians to join MACOA Health as clinical trial investigators, working alongside experienced research professionals to conduct clinical trials with access to cutting-edge technology and the latest scientific advancements.

Quantifiable outcome

• 72-hour regulatory document turnaround and 7-day clinical trial agreement turnaround
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered major and minor.

• AmgenmajorStrategic or Co-development PartnerMajor pharmaceutical sponsor. MACOA conducts clinical trials on behalf of Amgen evaluating new medications and treatments.
• AstraZenecamajorStrategic or Co-development PartnerMajor pharmaceutical sponsor. MACOA conducts clinical trials for AstraZeneca's respiratory and other therapeutic area medications.
• PfizermajorStrategic or Co-development PartnerMajor pharmaceutical sponsor. MACOA partners with Pfizer on clinical research studies.
• JanssenmajorStrategic or Co-development PartnerPharmaceutical sponsor under Johnson & Johnson. MACOA conducts clinical trials for Janssen.
• GSKmajorStrategic or Co-development PartnerMajor pharmaceutical sponsor (GlaxoSmithKline). MACOA partners with GSK on clinical research.
• Phoenix Prosperity PodcastminorGTM or Marketing PartnerPodcast platform that hosted MACOA to discuss their work and mission in the medical community.
• Native Connection InitiativesminorGTM or Marketing PartnerPodcast focused on Native American community health that featured MACOA's initiatives.

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Research Centers of America (RCA) / Accel Research Sites: Multi-therapeutic clinical research site network conducting respiratory, vaccine, dermatology, and infectious disease trials for major sponsors. Directly comparable to MACOA's model, though typically operating multiple U.S. locations.
• Worldwide Clinical Trials: Mid-sized CRO with deep respiratory, neuroscience, and infectious disease trial expertise, comparable to MACOA's therapeutic mix and sponsor profile but operating at significantly larger scale across multiple geographies.
• Celerion: Specialized early-phase / Phase I clinical research organization with on-site clinical pharmacology capacity. Highly comparable to MACOA's 17-bed Phase I and pharmacokinetic study capabilities, serving similar sponsor profiles in respiratory and other therapeutic areas.
• Quotient Sciences: Translational and early-phase clinical research organization with integrated clinical pharmacology units. Comparable to MACOA in early-phase execution model and pharma-sponsor customer base.

Broad incumbents

• ICON plc: Large CRO and clinical research site operator (including through its PRA Health Sciences and Symphony Health acquisitions) that runs multi-therapeutic trials for major pharma sponsors, overlapping MACOA's respiratory and vaccine trial work.
• Syneos Health (now private under Elliott/Veritas): Clinical and commercial solutions organization that includes a sizable site network (formerly Syneos Site Solutions / Clinique Labs) running respiratory and multi-therapeutic trials for top-20 pharma.
• Medpace: Mid-to-large CRO with significant respiratory and infectious-disease trial operations and embedded site-management capabilities, providing a directly comparable business model of full-service clinical research execution for sponsors.
• IQVIA (formerly Quintiles): Global CRO and site network that operates clinical research sites across therapeutic areas including respiratory. Comparable to MACOA in that it conducts sponsor-funded clinical trials and provides site-level services, but operates at vastly greater scale with thousands of sites globally.

Emerging players

• Citius Pharmaceuticals / Emerging Site Networks (e.g., Flourish Research): Independent, multi-specialty clinical research site networks (such as Flourish Research) operating multiple community sites across multiple U.S. states. Comparable to MACOA's community-based, multi-therapeutic site model and sponsor relationships, but with broader geographic reach.
• Highland Biosciences / local independent research sites: Local/regional independent clinical research sites in metro Phoenix and the Southwest that compete for the same sponsor respiratory and infectious-disease protocols and overlap with MACOA's investigator and patient pools.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/macoa-health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MACOA Health